Effect of IDH mutation on postoperative temozolomide chemotherapy and prognosis in anaplastic gliomas: a single-center retrospective study of 285 patients

Yang Pei; Wang Kuanyu; Zhang Chuanbao; Wang Zheng; You Gan; Shan Xia

doi:10.3969/j.issn.1009-6574.2021.05.004

Home>Articles>Effect of IDH mutation on postoperative temozolomide chemotherapy and prognosis in anaplastic gliomas: a single-center retrospective study of 285 patients

DOI: 10.3969/j.issn.1009-6574.2021.05.004

Effect of IDH mutation on postoperative temozolomide chemotherapy and prognosis in anaplastic gliomas: a single-center retrospective study of 285 patients

Yang Pei

Wang Kuanyu

Zhang Chuanbao

Wang Zheng

You Gan

Shan Xia

Machine-generated Keywords：

Publication Date：2021-05-20

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：9( 323-331 )

Journal of Neuroscience and Mental Health

ISTIC

ISSN：1009-6574

Year, Vol.(Issue)：2021,21(5)